Keyphrases
Statins
100%
Modulatory Effects
100%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
100%
Diabetic Microangiopathy
100%
Diabetes
37%
Pleiotropic Effects of Statins
37%
Beneficial Effects
25%
Isoprenoids
25%
Cardiovascular Mortality
12%
Intracellular Signaling
12%
Lipids
12%
Chronic Disease
12%
Clinical Benefit
12%
Endothelial Function
12%
Oxidative Stress
12%
Post-translational Modification
12%
Cholesterol
12%
Coronary Artery Disease
12%
Rate-limiting Enzyme
12%
Vascular Complications
12%
Coagulation
12%
Cholesterol Biosynthesis
12%
Small GTP-binding Proteins
12%
Plaque Stability
12%
Lipid-lowering
12%
Cholesterol-lowering
12%
Cardiovascular Morbidity
12%
Serum Cholesterol Level
12%
Competitive Inhibitor
12%
Plaque Inflammation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Oxidoreductase
100%
Diabetic Microangiopathy
100%
Glutaryl-CoA
100%
Isoprenoid
18%
Clinical Study
9%
Competitive Inhibitor
9%
Coronary Artery Disease
9%
Cardiovascular Mortality
9%
Chronic Disease
9%
Guanine Nucleotide Binding Protein
9%
Inflammation
9%
Neuroscience
Diabetes Mellitus
100%
Statin
100%
Isoprenoid
18%
G Protein
9%
Intracellular Signaling
9%
Oxidative Stress
9%
Posttranslational Modification
9%
Anabolism
9%
Competitive Inhibition
9%